2. 250-590-1718. Major Holdings. XBI has traded between $73. Net Expense Ratio. Free ratings, analyses, holdings, benchmarks, quotes, and news. XBI focuses on a narrow sector of the health care sector, and as such is probably too precise for most investors. Its holdings reflect the movement of like 750b worth of companies. -listed equities in the biotechnology sector. The sale of ETFs is subject to an activity assessment fee (from $0. Unlock comprehensive insights, track. All 33 ARKK ETF Holdings. 67. Below is the comparison between BBC and XBI. Dividend ETFs. Launched on 01/31/2006, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare . Check out the side-by-side comparison table of IBB vs. TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. MRTX. XBI focuses on health care investments and follows the S&P Biotech Index. 3% over the same period: Image Source: Zacks Investment Research. Learn everything about SPDR S&P Biotech ETF (XBI). Snapshot for the SPDR S&P BIOTECH ETF ETF (XBI), including recent quote, performance, objective, analyst opinions, and commentary. Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target. Performance and Risk. Actual Assets Under Management (AUM) is this value plus cash (which is not disclosed). 73m. 81 and $97. 37% in the last one. com) BioCryst , Biohaven , Exelixis , and AbbVie make up the remainder of the top 5. 1% which highlights the scope of the fund and diversification away from company-specific risks. The company’s fifty day. As I understand it, this attribute was added to the methodology to protect against having too. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF. 80 per share, with $92. In seeking to track the performance of the S&P Biotechnology Select. com. 90 in this past 52. Compare ETFs IBB and XBI on performance, AUM, flows, holdings, costs and ESG ratings. 06 and standard deviation of 38. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. S. 52 (-1. 12% in the. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. In that past 52-week period, it has traded between $62. 47 million over the past three months. The Global X Genomics & Biotechnology ETF (GNOM) seeks to invest in companies that potentially stand to benefit from further advances in the field of genomic science, such as companies involved in gene editing, genomic sequencing, genetic medicine/therapy, computational genomics, and biotechnology. Therapeutics Gene Therapy CAR-T Cell Therapy CRSPR Gene Editing. Based on its analysis of these factors, SSGA Funds Management, Inc. The weighted harmonic average of closing market price divided by. 23%) Advertisement SPDR S&P Biotech ETF (XBI) NYSEArca - NYSEArca Delayed Price. 74. Performance. XBI, BEAM, FATE, NTLA: ETF Outflow Alert. Regeneron has an overall rating of B in our POWR Ratings, where it outranks 79. GrowthStrategy: Traditional growth investing is an investment. Expense ratio and liquidity are average for the group. $7. 6% of the fund. XBI has a higher expense ratio than XLV (0. Taking a look at the XBI, it peaked at $174. 97. 26 during this last 52-week period. Shares Held Weight In Fund. Components of. XBI, TGTX, VKTX, NVAX: Large Outflows Detected at ETF. 48%: Number of Holdings 78: Price/Book Ratio Price/Book Ratio. Looking at the chart above, XBI's low point in its 52 week range is $62. ETF Constituents for S&P Biotech SPDR (XBI) provide detail on the individual stock holdings that make up the ETF. Top 10 Holdings % Portfolio Weight Market Value USD Sector State Street Instl US Govt MMkt Premier 56. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. Looking at the chart above, XBI's low point in its 52 week range is $63. 60 as the 52 week high point — that compares with a last trade of $77. Most recent portfolio value is calculated to be $ 7,141,224,184 USD. Holdings. ETF Channel Staff - Friday, October 20, 6:48 AM. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one. 96% vs -5. 2. This index comprises companies in the biotech industry that are a part of the S&P Total Market Index. Analyst Forecast. 7% of assets. LABD. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). (XBI) SPDR S&P Biotech ETF Stock Price, Holdings,. ETF Channel Staff - Friday, October 20, 6:48 AM. Neena Mishra May 10, 2023. Before you invest in the SPDR ® S&P Biotech ETF (the “Fund”), you may want to review the Fund's prospectus and statement of additional information, which contain more information about the Fund and the risks of investing in the Fund. 61%) 13,857,540 Average : As of close 11/17/2023: Summary; News; Charts;. Site search Search. Performance. Rated on Jun 30, 2023 Published on Jun 30. Its fund flows were negative $259. February 15, 2023 — 10:47 am EST. 40. 72%: Data delayed at least 15 minutes, as of Nov 16 2023 21:00 GMT. XBI is a modified equal weighted ETF with about 157 holdings, though that number may change due to issues such as being acquired, among others. Meanwhile, XBI equal weights its holdings. Total healthcare and life sciences M&A was about $71. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. The fund employs an equal-weighted methodology, providing a balanced allocation across small, mid, and large-cap biotech companies. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. SPDR® S&P Biotech ETF XBI: NYSE Arca . However, XBI has a built-in advantage that was mentioned earlier: It owns stocks in relatively equal weights. Sector ETFs. 8% of its total assets under management. 12 and $91. Launched on 01/31/2006, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market. Top holding Madrigal Pharmaceuticals (NASDAQ:MDGL) makes up just a 3. 40 for Nov. 2 %. 98 and standard deviation of 40. Performance and Risk The ETF has lost about -29. 5% year-to-date and 38. The top holding in XBI receives just a 1. The XBI is a modified equally weighted index and includes many well known mid-cap stocks with momentum that are likely to move up in a sector rally. Additionally, where applicable, foreign currency exchange rates with respect to the portfolio holdings denominated in non-U. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. ARKG is an actively managed Exchange Traded Fund (ETF) that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy, and consumer. 94 as the 52 week high point — that compares with a last trade of $116. The fund employs an equal-weighted methodology, providing a balanced allocation across small, mid, and large-cap biotech companies. The ETF return is roughly 4. ($423. 2B. AMGN. Below is the comparison between LABU and XBI. View the XBI funds market news. 7 days ago - Exploring Economic Indicators: Household Debt, Consumer Sentiment, and Trade - ETF Trends 14 days ago - What's Happening in the Labor Market? - ETF Trends ; 21 days ago - GDP Surges as Sentiment Slides: A Week of Economic Insights - ETF Trends 25 days ago - Consumer Discretionary vs. The company’s fifty day. 04 per unit, that means that analysts see 73. 81. 01%). The top 10 holdings account for about 10. The best stock comparison tool in Galaxy! Pick any two stocks and find out how much money each would've made you had you purchased them at the same time. Name Symbol % Assets. XBI: SPDR® S&P Biotech ETF: 1. The XBI has been a leader beating other ETFs YTD, up about 35% until today. Looking at the chart above, XBI's low point in its 52 week range is $62. XBI vs BBH. View the real-time XBI price chart on Robinhood and decide if you want to buy or sell commission-free. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (AMEX: XBI) where we have detected an. IBB has 8. 79 as the 52 week high point — that compares with a last trade of $133. 79 in February 2021 and has fallen over (50%) to $76. 33% from the latest price. News & World Report, XBI enjoys volume of 20. Seeks to track a modified equal weighted index which provides the potential for unconcentrated industry exposure across large, mid and small cap stocks. 35%. Region Percentage; North, Central and South America: 99. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. The fund has a beta of 0. Consumer Staples Select Sector SPDR ETF ETF holdings by MarketWatch. View daily, weekly or monthly formats back to when SPDR S&P Biotech ETF stock was issued. S. Mirati. SPDR® S&P Biotech ETF XBI: NYSE Arca All Holdings as of 11/15/2023 Holdings are subject to change. Fund Analysis. The "A+ Metric Rated ETF" field, available to ETF Database Pro members, highlights the best rated ETF in the Emerging Markets Equities category. View the XBI funds market news. 8% of its total assets under management. 42 billion worth of net assets. It is gross of any fee waivers or expense reimbursements. 06 as the 52 week high point — that compares with a last trade of $109. The company has an 88. Stocks. XBI Portfolio - Learn more about the SPDR® S&P Biotech ETF investment portfolio including asset allocation, stock style,. Check out the side-by-side comparison table of XBI vs. 81 and $134. XBI has a beta of 1. The next columns indicate the amount of XBI stock held by each of the funds holding XBI, followed by the XBI position size held by the fund, and lastly the date of the quarterly filing period the data represents. iShares Biotechnology ETF ETF holdings by MarketWatch. View complete XBI exchange traded fund holdings for better informed ETF trading. The iShares Core S&P 500 ETF Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of U. Cash and Equivalents. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at , one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where. Viehbacher reported, “In the second quarter, Biogen continued to advance groundbreaking science with the FDA approval of two first-in-class therapies for Alzheimer’s disease and ALS, while also delivering on our. 3. A few losers won't cause XBI to crash. The S&P Biotechnology Select Industry Index comprises stocks in the S&P Total Market Index that are classified in the GICS Biotechnology sub-industry. 47% vs -5. Holdings Details. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. We have highlighted five ETFs from different. The portfolio maintains a cost advantage over competitors, priced within the cheapest fee quintile among peers. 78%) has been the biggest winner, with its shares jumping nearly 40% year to date. S. SPDR S&P BIOTECH ETF. XBI holdings. 7,569,600. 75M), Brown Advisory. 22%: Revolution. 27%: Number of Holdings 29: Price/Book Ratio Price/Book Ratio. The firm has a market cap of $5. 96%, and is down about -5. Twin City Holdings Ltd. The table below compares many ETF metrics between IBB and XBI. The quantity of holdings in the Fund will be based on a number of factors, including asset size of the Fund. The first column indicates the name of each of the funds holding XBI, with a link to that fund's top holdings. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. 35% vs 0. 0. View Top Holdings and Key Holding Information for Direxion Daily S&P Biotech Bull 3X Shares (LABU). 26 during this last 52. . The Fund's prospectus and statement of additional information dated October 31, 2015, are incorporated by reference into this. 73. 85. 69% allocation. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. 58%). XBI has a lower 5-year return than XLV (-5. The best stock comparison tool in Galaxy! Pick any two stocks and find out how much money each would've made you had you purchased them at the same time. 1 Day NAV Change as of Nov 09, 2023. 95. Performance and Risk The ETF has lost about -9. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. $6. 84% for the trailing three-year period, which makes the fund a high risk choice in the space. Compare ETFs XBI and IBB on performance, AUM, flows, holdings, costs and ESG ratings. $0. 32% Category Average 45. XBI is suitable for investors seeking to. WIX. View complete XBI exchange traded fund holdings for better informed ETF trading. Performance and Risk. 2. XBI Holdings 5 Beaten-Down ETFs to Buy Now. Netherlands. 15 billion assets under management. There are a number of factors behind this strategy, the overriding one being that biotech has pulled back in the fall a large percentage of the. Implied XBI Analyst Target Price: $135. XBI's top 10 holdings account for about 11. The fund's investments total to approximately $6. 97. Cryptocurrency. View complete XLP exchange traded fund holdings for better informed ETF trading. 60 as the 52 week high point — that compares with a last trade of $77. 47 and a beta of 0. XBI touched $73. Brazil. Currency in USD. , and Amgen Inc. So far this year, XBI has lost about -5. Below is the comparison between BBH and XBI. ARKK ARKG. Complete SPDR S&P Biotech ETF funds overview by Barron's. A lot of these companies can't survive unless someone with deep pockets is willing to pay boatloads of money for the treatments/cures they're developing. DLTR. 1. Our MRNA ETF report shows the ETFs with the most MRNA exposure, the top performing MRNA ETFs, and most popular MRNA ETF strategies. IBB has a higher 5-year return than XBI (0. Chart. XBI's 120. SPDR S&P Biotech ETF is a equity fund issued by SSgA. XBI, the SPDR S&P Biotech ETF, tracks the performance of the S&P Biotechnology Select Industry Index, offering exposure to the biotechnology sector. 89%. Track SPDR Biotech ETF (XBI) Stock Price, Quote, latest community messages, chart, news and other stock related information. As of Oct 31 2023. 0. IBB outperformed the S&P 500 last year and did much better than XBI. SPDR® S&P Biotech ETF. Published. The top XBI holdings:Glossary: ActiveShareis a measure of the percentage of stock holdings in a manager's portfolio that differ from the benchmark index. Sector Exposure and Top Holdings. 01 to $0. Shares of XBI stock opened at $73. The iShares Biotechnology ETF seeks to track the investment results of an index composed of U. Royal Gold Inc. And, again, it is in the top 15 holdings by weighting of the. It's trading down (17%) versus LABU, down (68%) in one-year performance. This fee is shown as an annual percentage rate (APR). The gross expense ratio is the fund’s total annual operating expenses ratio. 31 per share, with $92. L ooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI. Here, we set out to define in detail the pharmacokinetics of a well-characterized IDR molecule, IDR-1018. We have highlighted five ETFs from different. Fund size is a good indication of how many other investors trust this fund. It can be found in the fund’s most recent prospectus. Lens & Shutter Holdings Ltd. ARKG is an actively managed Exchange Traded Fund (ETF) that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy, and consumer. The current portfolio value is calculated to be $6. By Holdings Channel Staff, updated Friday, November 3, 9:50 AM In total we count 672 hedge funds holding XBI as of their latest 13F filing, but among those we've sorted out just the top ten hedge funds holding XBI by largest position size, and presented them here in slideshow format. L ooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P. S. In its most recent earnings release, President and Chief Executive Officer Christopher A. Also includes news, ETF details and other investing information. BlackRock Files for Spot Ethereum ETF. 35%). No, even the large cap biotechs get pumped before a final FDA decision on a drug in their pipeline and usually have a sell off after on profit taking or a failed decision. Analysis of these related ETFs and how they are trading may provide insight to this commodity. Net expense ratio. Wix. 47% vs -5. 07. 35 %LABU: S&P Biotech Bull 3X Shares ETF:Finally, our fifth stock in our POWR Ratings/XBI combination strategy is Regeneron . Minafi categorizes both of these funds as large funds. , including minimum market capitalization and. IMVT. Holdings. 67. Regeneron has an overall rating of B in our POWR Ratings, where it outranks 79. 2014. m. XBI has traded between $64. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. Diversification. View Holdings As of 09/30/2023. $0. 64 per share, with $174. XBI, MDGL, ARWR, CYTK: Large Inflows Detected at ETF. 53 (+3. 09% of its total assets under management. The ETF has lost about -12. 7% of assets. Performance and Risk. XBI SPDR S&P Biotech ETF ARKG ARK Genomic Revolution ETF IBB iShares Biotechnology ETF IHI iShares U. In depth view into XBI Price including historical data from 2006, charts and stats. Top 10 Holdings (14. As a result, the ETF reached a new 8-month low. News, commentary and events are from third-party sources unaffiliated with Fidelity. View Holdings As of 08/31/2023. 46% YTD Daily Total ReturnETF Summary. Oct 10, 2022 01:14PM EDT. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. Its fund flows were negative $259. Mirati Therapeutics. 7042%). XBI has traded between $62. 01%). 09%: Canada: 1. XBI has a Diversified Portfolio. Mettler-Toledo International Inc. 26 during this last 52-week period. 9%: Israel: 3. 50. 1 Y 3 Y $ % Advanced Charting Compare Compare to Benchmark: DJIA S&P 500 GLOBAL DOW NASDAQ Compare to Open 70. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. $72. Find the latest SPDR® S&P Biotech ETF (XBI) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears. 2401 Millstream Rd 125 Victoria BC. It is gross of any fee waivers or expense reimbursements. 12% in the. The top 10 holdings account for about 11. At midday the XBI is rebounding indicating there is buying interest near $101. Again, top 10 holdings. Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund launched on 01/31/2006. Growth of Hypothetical $10,000. 38%. 94 per share, with $107. While this ETF allocates. Explore FBT for FREE on ETF Database: Price, Holdings, Charts, Technicals, Fact Sheet, News, and more. Looking at the chart above, XBI's low point in its 52 week range is $72. *Close price adjusted for splits. Holdings AS OF 04/30/2023. Download as Image. XBI, whose index recently expanded, also owns only a handful of established biotech companies. $156. 49. 73% so far this year and is down about -39. ETF Strategies. 20. 78% of XBI's total assets under management. 79 in February 2021 and has fallen over (50%) to $76. Lucy Brewster | Nov 10, 2023. 73. 56% vs 0. Fidelity does not endorse or adopt their content. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. 58%: Halozyme Therapeutics Inc:How To Invest / Fund Directory / ARK Genomic Revolution ETF vs SPDR S&P Biotech ETF . 12% in the last one year (as of 03/16/2023). Learn everything about SPDR S&P Biotech ETF (XBI). XBI – SPDR® S&P Biotech ETF – Check XBI price, review total assets, see historical growth, and review the analyst rating from Morningstar.